Andar poluído

Na sequência daquilo que já intuímos em continuadas reflexões, sentimos na prática e confirmámos em diversas leituras, divulgamos um artigo publicado, no último número da revista The Lancet, sobre o impacte da prática de caminhada sob condições de exposição a ar poluído. Facilmente se poderão extrapolar os possíveis efeitos perniciosos naqueles que efectuam treinos regulares de marcha rápida ou, por razões acrescidas, de corrida e/ou de bicicleta em ambientes urbanos, mormente em ruas com intenso tráfego motorizado!...

Para ter acesso ao artigo completo e às respectivas notas, consulte a edição de hoje da The Lancet.

©  na Net (?)

«There is a well documented association between human exposure to fine particulate matter air pollution (PM_2.5) and an increased risk of cardiovascular disease and death.^1, 2 Indeed, the Global Burden of Disease (GBD) study³ recently estimated that exposure to PM_2·5 contributed to 4·2 million deaths in 2015, representing the fifth-ranked risk factor for global deaths; of these, mortality from cardiovascular disease (CVD; ie, ischaemic heart disease and cerebrovascular disease) accounted for most deaths attributed to ambient PM_2·5 air pollution. However, despite these strong epidemiological associations and the documented widespread adverse health effects, the exact biological mechanisms and the types of particles that are most responsible for the PM_2.5–CVD associations are not well defined.

In The Lancet, Rudy Sinharay and colleagues⁴ use a simple but elegant randomised crossover design to gain insight into the type of pollution that can lead to the air pollution–CVD associations that have been reported in population-based epidemiological studies, as well as to identify specific cardiovascular changes consistent with the causality of those associations. The researchers studied the effects of traffic pollution exposure in adult participants aged 60 years and older during a 2 h walk along a busy commercial street in London, England (Oxford Street) compared with a similar walk in a nearby London park (Hyde Park), which has much lower air pollution. 40 healthy volunteers, 40 participants with chronic obstructive pulmonary disease, and 39 participants with ischaemic heart disease took part. In all 119 participants, irrespective of disease status, walking in Hyde Park led to an increase in lung function and a decrease in arterial stiffness, measured as pulse wave velocity and augmentation index, following the walk. By contrast, these beneficial responses were significantly diminished after walking along the more polluted Oxford Street. Specifically, among healthy volunteers the investigators reported a roughly 5% (95% CI −10·40 to −0·27) decrease in pulse wave velocity from 2 to 26 h after the Hyde Park walk, an exercise benefit that was not only negated but even reversed 26 h after the Oxford Street walk (7% increase in pulse wave velocity, 95% CI 2·16 to 12·20). Thus, the multifactorial benefits of low-to-moderate intensity physical activity, such as walking, for the primary and secondary prevention of CVD⁵ were offset by the presence of air pollution. Reductions in measures of arterial stiffness have been recorded with the use of guideline-directed medical therapy;⁶ however, until this study, evidence has been scarce on the adverse effects of air pollution exposure on vascular function during physical activity.⁷

Important to the interpretation of this study is the finding that air pollution causes phospholipid oxidation⁸ and oxidative stress (eg, by transition metals in fossil fuel combustion particles).⁹ These pathways accelerate atherogenesis and increase arterial stiffness, itself a strong predictor of cardiovascular events and all-cause mortality.¹⁰ However, one limitation of such panel studies is their size; as such, generalisability can be an issue. In view of this limitation, more and larger practical real-world exposure studies like the one done by Sinharay and colleagues⁴ that also assess novel in-vivo biomarkers of oxidative stress and phospholipid oxidation might further clarify the mechanistic pathways and clinical implications of air pollution exposure, and broaden their known applicability. Furthermore, additional evidence on the temporal relationships and longer-term cumulative effects of chronic air pollution on arterial stiffness is also needed. Overall, however, data from Sinharay and colleagues provide significant new evidence of an important biological pathway between subclinical CVD and the systemic effects of air pollution exposure. (…)»

REFERÊNCIA BIBLIOGRÁFICA

THURSTON, George D. & NEWMAN, Jonathan D.. Walking to a pathway for cardiovascular effects of air pollution. The Lancet, vol. 391, nº 10118, 27/Jan. 2018, p. 291-292